KYGEVVI 2 g/1
doxecitine and doxribtimine · POWDER, FOR SOLUTION · UCB, Inc.
No Recall History
Plain English
KYGEVVI is a powder, for solution containing doxecitine and doxribtimine at 2 g/1, taken oral. Manufactured by UCB, Inc..
Key Facts
- Brand Name
- KYGEVVI
- Generic Name
- doxecitine and doxribtimine
- NDC Code (Product)
50474-350- Manufacturer
- UCB, Inc.
- Strength
- 2 g/1
- Dosage Form
- POWDER, FOR SOLUTION
- Route
- ORAL
- Marketing Status
- Application #
- NDA219792
- Marketing Start
- 03/01/2026
Recall History
No Recall HistoryFrequently Asked Questions
What is KYGEVVI used for?
KYGEVVI contains doxecitine and doxribtimine. It is a powder, for solution taken oral. Consult your doctor for specific uses.
Is KYGEVVI a controlled substance?
KYGEVVI is not classified as a controlled substance by the DEA.
What is the generic name for KYGEVVI?
The generic name for KYGEVVI is doxecitine and doxribtimine. There are no other listed brand versions of doxecitine and doxribtimine.
What is the NDC code for KYGEVVI 2 g/1?
The NDC (National Drug Code) for KYGEVVI 2 g/1 is 50474-350, listed by UCB, Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)